• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西腹膜透析患者的公共卫生投资与死亡风险

Public health investments and mortality risk in Brazilian peritoneal dialysis patients.

作者信息

Loesch Gustavo, Cruz June A W, Pecoits-Filho Roberto, Figueiredo Ana E, Barretti Pasqual, de Moraes Thyago P

机构信息

Programa de Pós-Graduação em Ciências da Saúde da Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba, Brazil.

Programa de Pós-Graduação em Administração da Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba, Brazil.

出版信息

Clin Kidney J. 2020 Jul 16;13(6):1012-1016. doi: 10.1093/ckj/sfaa118. eCollection 2020 Dec.

DOI:10.1093/ckj/sfaa118
PMID:33391744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7769512/
Abstract

BACKGROUND

End-stage kidney disease (ESKD) treatment is very costly and accounts for a significant percentage of public healthcare expenditures. Beyond direct costs, dialysis patients use other healthcare levels, but the impact of public investment on each of these levels is unclear. This study aimed to investigate the association between direct financing at different healthcare levels and overall mortality in peritoneal dialysis (PD) patients.

METHODS

We included all adult incident PD patients from a Brazilian prospective, nationwide PD cohort. Overall mortality was the primary outcome of interest. We used a three-level multilevel survival analysis to investigate whether mortality was associated with the investments destined to different levels of healthcare complexity: (i) primary, (ii) medium and high and (iii) professional healthcare training and community awareness.

RESULTS

We evaluated 5707 incident PD patients from 78 Brazilian cities, which were divided into four quartiles for each healthcare level (Groups I-IV). After taking the highest quartile (Group IV) as a reference, investment in the primary health level was not associated with patient survival. Otherwise, medium and high complexity levels were associated with higher mortality risk. Also, investment in healthcare manager training and community awareness had an impact on patient survival.

CONCLUSIONS

Investments in different levels of the healthcare system have distinct impacts on PD patient survival. Investment in healthcare manager training and community awareness seems to be a promising strategy on which to focus, given the relatively low cost and positive impact on outcome.

摘要

背景

终末期肾病(ESKD)的治疗成本非常高昂,在公共医疗支出中占很大比例。除了直接成本外,透析患者还使用其他医疗服务层级,但公共投资对这些层级中每一层级的影响尚不清楚。本研究旨在调查不同医疗服务层级的直接融资与腹膜透析(PD)患者总体死亡率之间的关联。

方法

我们纳入了巴西一项前瞻性全国性PD队列中的所有成年新发PD患者。总体死亡率是主要关注的结局。我们采用三级多水平生存分析来调查死亡率是否与针对不同医疗复杂程度层级的投资相关:(i)初级,(ii)中高级,以及(iii)专业医疗培训和社区认知。

结果

我们评估了来自巴西78个城市的5707例新发PD患者,每个医疗服务层级分为四个四分位数(I - IV组)。以最高四分位数(IV组)为参照,对初级卫生层级的投资与患者生存率无关。相反,中高复杂程度层级与更高的死亡风险相关。此外,对医疗管理人员培训和社区认知的投资对患者生存率有影响。

结论

医疗系统不同层级的投资对PD患者生存率有不同影响。鉴于成本相对较低且对结局有积极影响,对医疗管理人员培训和社区认知的投资似乎是一个值得关注的有前景的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b88/7769512/7c67edd428c3/sfaa118f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b88/7769512/7c67edd428c3/sfaa118f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b88/7769512/7c67edd428c3/sfaa118f1.jpg

相似文献

1
Public health investments and mortality risk in Brazilian peritoneal dialysis patients.巴西腹膜透析患者的公共卫生投资与死亡风险
Clin Kidney J. 2020 Jul 16;13(6):1012-1016. doi: 10.1093/ckj/sfaa118. eCollection 2020 Dec.
2
Characterization of the BRAZPD II cohort and description of trends in peritoneal dialysis outcome across time periods.BRAZPD II队列的特征及不同时间段腹膜透析结局趋势的描述。
Perit Dial Int. 2014 Nov-Dec;34(7):714-23. doi: 10.3747/pdi.2013.00282. Epub 2014 Sep 2.
3
Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies.医疗保健系统与终末期肾病(ESRD)治疗——一项国际综述:ESRD治疗的成本及报销/资金情况
Nephrol Dial Transplant. 1999;14 Suppl 6:31-41. doi: 10.1093/ndt/14.suppl_6.31.
4
Family income and survival in Brazilian Peritoneal Dialysis Multicenter Study Patients (BRAZPD): time to revisit a myth?巴西腹膜透析多中心研究患者的家庭收入与生存情况(BRAZPD):是时候重新审视一个神话了吗?
Clin J Am Soc Nephrol. 2011 Jul;6(7):1676-83. doi: 10.2215/CJN.09041010. Epub 2011 Jun 23.
5
[Current peritoneal dialysis compared with haemodialysis: medium-term survival analysis of incident dialysis patients in the Canary Islands in recent years].[近年来加那利群岛新入透析患者的中期生存分析:当前腹膜透析与血液透析的比较]
Nefrologia. 2011;31(2):174-84. doi: 10.3265/Nefrologia.pre2011.Jan.10743.
6
Impact of baseline health-related quality of life scores on survival of incident patients on peritoneal dialysis: a cohort study.基线健康相关生活质量评分对新发腹膜透析患者生存的影响:一项队列研究。
Nephron. 2015;129(2):97-103. doi: 10.1159/000369139. Epub 2015 Jan 28.
7
Brazilian Peritoneal Dialysis Multicenter Study (BRAZPD): from conception to execution of a national peritoneal dialysis reality check.巴西腹膜透析多中心研究(BRAZPD):从构思到全国腹膜透析现状核查的实施
Contrib Nephrol. 2012;178:23-29. doi: 10.1159/000337793. Epub 2012 May 25.
8
Comparable outcome of acute unplanned peritoneal dialysis and haemodialysis.急性非计划性腹膜透析与血液透析的可比结局。
Nephrol Dial Transplant. 2012 Jan;27(1):375-80. doi: 10.1093/ndt/gfr262. Epub 2011 May 28.
9
Association of Socio-Economic Position with Technique Failure and Mortality in Australian Non-Indigenous Peritoneal Dialysis Patients.澳大利亚非土著腹膜透析患者社会经济地位与技术失败和死亡率的关联
Perit Dial Int. 2017 Jul-Aug;37(4):397-406. doi: 10.3747/pdi.2016.00209. Epub 2017 Feb 9.
10
The Impact of Timing of Dialysis Initiation on Mortality in Patients with Peritoneal Dialysis.腹膜透析患者开始透析的时机对死亡率的影响。
Perit Dial Int. 2015 Dec;35(7):703-11. doi: 10.3747/pdi.2013.00328. Epub 2014 Oct 7.

引用本文的文献

1
Comparison of 1-year survival between patients initiating chronic hemodialysis under public and private health insurance: register-based data analysis from Brazil.比较公共和私人医疗保险下开始慢性血液透析的患者 1 年生存率:来自巴西的基于登记数据的分析。
Int Urol Nephrol. 2024 Sep;56(9):3013-3022. doi: 10.1007/s11255-024-04018-4. Epub 2024 Apr 5.
2
Characteristics and 1-year survival of incident patients on chronic peritoneal dialysis compared with hemodialysis:a large 11-year cohort study.慢性腹膜透析与血液透析新发病例患者的特征及1年生存率:一项为期11年的大型队列研究
Int Urol Nephrol. 2023 Aug;55(8):2025-2033. doi: 10.1007/s11255-023-03489-1. Epub 2023 Feb 21.
3

本文引用的文献

1
International Society for Peritoneal Dialysis practice recommendations: Prescribing high-quality goal-directed peritoneal dialysis.国际腹膜透析学会实践建议:开具高质量目标导向性腹膜透析处方
Perit Dial Int. 2020 May;40(3):244-253. doi: 10.1177/0896860819895364. Epub 2020 Jan 21.
2
2005 Guidelines on targets for solute and fluid removal in adults being treated with chronic peritoneal dialysis: 2019 Update of the literature and revision of recommendations.2005 年成人慢性腹膜透析溶质和液体清除目标指南:文献更新和推荐意见修订。
Perit Dial Int. 2020 May;40(3):254-260. doi: 10.1177/0896860819898307. Epub 2020 Jan 14.
3
Adherence to multidisciplinary care in a prospective chronic kidney disease cohort is associated with better outcomes.
在一个前瞻性慢性肾脏病队列中,坚持多学科治疗与更好的结局相关。
PLoS One. 2022 Oct 14;17(10):e0266617. doi: 10.1371/journal.pone.0266617. eCollection 2022.
4
Use of paclitaxel carried in solid lipid nanoparticles to prevent peritoneal fibrosis in rats.紫杉醇固体脂质纳米粒给药预防大鼠腹膜纤维化。
PLoS One. 2022 May 6;17(5):e0268197. doi: 10.1371/journal.pone.0268197. eCollection 2022.
5
The unaccomplished mission of reducing mortality in patients on kidney replacement therapy.在接受肾脏替代治疗的患者中降低死亡率这一未完成的使命。
Clin Kidney J. 2020 Nov 30;13(6):948-951. doi: 10.1093/ckj/sfaa235. eCollection 2020 Dec.
Peritoneal Dialysis-Related Infection Rates and Outcomes: Results From the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS).
腹膜透析相关感染率和结局:来自腹膜透析结局和实践模式研究(PDOPPS)的结果。
Am J Kidney Dis. 2020 Jul;76(1):42-53. doi: 10.1053/j.ajkd.2019.09.016. Epub 2020 Jan 10.
4
The Executive Order on Kidney Care: An Opportunity to Improve Outcomes for Individuals With Kidney Disease.关于肾脏护理的行政命令:改善肾病患者治疗效果的契机。
Kidney Int Rep. 2019 Sep 18;4(11):1519-1522. doi: 10.1016/j.ekir.2019.09.011. eCollection 2019 Nov.
5
The Brazilian health system at crossroads: progress, crisis and resilience.处于十字路口的巴西卫生系统:进步、危机与韧性。
BMJ Glob Health. 2018 Jul 3;3(4):e000829. doi: 10.1136/bmjgh-2018-000829. eCollection 2018.
6
Expenses of the Brazilian Public Healthcare System with chronic kidney disease.巴西公共医疗系统在慢性肾病方面的支出。
J Bras Nefrol. 2018 Apr-Jun;40(2):122-129. doi: 10.1590/2175-8239-JBN-3918. Epub 2018 Jun 4.
7
Comparison of Patient Survival Between Hemodialysis and Peritoneal Dialysis Among Patients Eligible for Both Modalities.适合两种治疗模式的患者中,血液透析与腹膜透析患者的生存比较。
Am J Kidney Dis. 2018 Mar;71(3):344-351. doi: 10.1053/j.ajkd.2017.08.028. Epub 2017 Nov 22.
8
Analysis of economic impact between the modality of renal replacement therapy.肾替代治疗方式之间的经济影响分析。
J Bras Nefrol. 2017 Apr-Jun;39(2):162-171. doi: 10.5935/0101-2800.20170019. Epub 2017 Apr 27.
9
Characterization of the BRAZPD II cohort and description of trends in peritoneal dialysis outcome across time periods.BRAZPD II队列的特征及不同时间段腹膜透析结局趋势的描述。
Perit Dial Int. 2014 Nov-Dec;34(7):714-23. doi: 10.3747/pdi.2013.00282. Epub 2014 Sep 2.
10
Cost of peritoneal dialysis and haemodialysis across the world.全球腹膜透析和血液透析的成本。
Nephrol Dial Transplant. 2013 Oct;28(10):2553-69. doi: 10.1093/ndt/gft214. Epub 2013 Jun 4.